Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Cullis Laboratory | Department of Biochemistry and Molecular Biology | Faculty of Medicine Compensation Range $4,207.63 - $5,005.45 CAD Monthly Posting End Date April 24, 2024 Note: Applications will be
-
information on the lab is available at https://pavlab.msl.ubc.ca . The Michael Smith Laboratories (MSL; https://www.msl.ubc.ca/) is a dynamic hub for groundbreaking research and education excellence. Our highly
-
RNA Therapeutics to join a dynamic and multidisciplinary team under the co-supervision of Dr. Anna Blakney and Dr. Jay Kizhakkedathu. The successful candidate will work on a project to develop new
-
joining a dedicated, dynamic and highly motivated team within the RNA & Formulation Core, a cost recovery service facility. The primary focus will be to ensure the generation of high-quality RNA
-
position involves providing technical support in the areas of molecular biology, biochemistry and cell biology for researchers on current ongoing research projects. Individuals should possess a strong
-
creates the necessary conditions for a rewarding career. Job Summary The successful candidate will be responsible for the growth and expansion of the Molecular and Advanced Pathology Core (MAPcore) lab
-
, the candidate will actively contribute to the development of novel molecular methods for pathogen detection, which will be implemented in the BCCDC PHL (British Columbia Centre for Disease Control Public Health
-
and undergraduate students, gain leadership experience in collaborative projects and contribute to grant applications. The incumbent will be part of a dynamic team of experimental scientists, where
-
at the University of British Columbia, Vancouver campus, invites applications for one full time non-tenure track faculty at the Lecturer rank with expertise in nursing clinical skills lab and simulation education to
-
atherosclerotic lesions (or plaques) that are made of diseased cells build up in blood vessels. Different from the traditional assumption that larger lesions are riskier to cause cardiovascular events, molecular